Related Experiment Video
Updated: Apr 15, 2026

07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
10.6K
Simple Method to Genotype the ACTN3 r577x Polymorphism
Ines Schadock1, Augusto Schneider, Elton Dias Silva
11 Laboratory of Nutrigenomics and Metabology, Federal University of Pelotas , Pelotas, Rio Grande do Sul, Brazil .
Genetic Testing and Molecular Biomarkers
|April 2, 2015
Summary
A new, cost-effective single PCR method accurately genotypes the alpha-actinin-3 (ACTN3) r577x polymorphism. This technique simplifies genetic analysis for athletic performance studies.
Area of Science:
- Genetics
- Sports Science
- Molecular Biology
Background:
- The alpha-actinin-3 (ACTN3) gene's r577x polymorphism (rs1815739) significantly influences athletic performance.
- The R allele is linked to powerful muscle contractions, while the X allele is associated with enhanced energy efficiency.
- Current genotyping methods like RFLP and real-time PCR are costly and equipment-intensive.
Purpose of the Study:
- To develop a simple, cost-efficient single PCR method for ACTN3 r577x polymorphism genotyping.
- To provide a validated alternative to existing, more expensive genotyping techniques.
Main Methods:
- A novel four-primer single PCR assay was designed.
- External primers amplify a 690-bp product for quality control.
- Internal primers generate allele-specific products: 413-bp for R allele, 318-bp for X allele.
Main Results:
- The developed single PCR method accurately genotypes the ACTN3 r577x polymorphism.
- Results were validated against standard real-time PCR methods.
- The assay is suitable for both small and large-scale cohort studies.
Conclusions:
- This single PCR protocol offers a cost-effective and accurate solution for ACTN3 r577x genotyping.
- The method simplifies genetic analysis in sports science and related fields.
- It enables wider accessibility for research on athletic performance genetics.
More Related Videos
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
71
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
71
Incomplete Dominance
32.8K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.8K
Single Nucleotide Polymorphisms-SNPs
20.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
20.2K

